Restarting GLP-1 therapy produces weight loss again, though some research suggests the response may be slightly less dramatic on a second course
This shift does not diminish the importance of safety, but it underscores the need to evaluate peptide systems within an appropriate therapeutic context rather than through overly conservative early-stage filters
Insulin is a hormone made by the pancreas that helps move glucose from the bloodstream into cells, particularly in muscle and fat tissue, where it can be used for energy
Factors like age, hormonal status, existing medical conditions, and concurrent medications all influence both the likelihood and severity of GLP-1 related dry mouth
A study found that while the drug is effective in weight management throughout therapy, discontinuing use will result in the patient regaining weight
This can be useful as a starting point, but it can also be misleading